Acceptability of lopinavir/r pellets (minitabs), tablets and syrups in HIV-infected children. - Wikidata - awgldk - TriplyDB

Acceptability of lopinavir/r pellets (minitabs), tablets and syrups in HIV-infected children.

Acceptability of lopinavir/r pellets (minitabs), tablets and syrups in HIV-infected children.

http://www.wikidata.org/entity/Q38854786

about

Efavirenz-based simplification after successful early lopinavir-boosted-ritonavir-based therapy in HIV-infected children in Burkina Faso and Côte d'Ivoire: the MONOD ANRS 12206 non-inferiority randomised trial.Understanding the acceptability and adherence to paediatric antiretroviral treatment in the new formulation of pellets (LPV/r): the protocol of a realist evaluation.Moving forward with treatment options for HIV-infected children.Virological response and resistances over 12 months among HIV-infected children less than two years receiving first-line lopinavir/ritonavir-based antiretroviral therapy in Cote d'Ivoire and Burkina Faso: the MONOD ANRS 12206 cohort.Oral medicine acceptance in infants and toddlers: measurement properties of the caregiver-administered Children's acceptance tool (CareCAT).Acceptability of placebo multiparticulate formulations in children and adults.Optimizing Clinical Trial Design to Maximize Evidence Generation in Pediatric HIV Propelling the Pediatric HIV Therapeutic Agenda With Science, Innovation, and Collaboration

P2860

Q33593775-66BD3B04-8E43-48B5-9DF2-217304D737D5 Q37728208-BBBD118F-3ABF-42BD-A48C-87389CF13F2D Q40063042-0A2D1436-2A8C-48E0-BE08-88FEF9DFA9EF Q40223405-2C25AF5E-734A-4083-8265-FCE6A78AB303 Q53699367-BA30D92A-2B9C-48F9-AD73-9710CD8C481E Q55424420-F8B46C05-AA12-4564-9798-9A101D30F61A Q56910418-1145B602-7262-451D-A0E9-E4BBC32FB7B7 Q56969729-187BC419-8046-4C9A-B22C-8A443E58B948

P2860

Acceptability of lopinavir/r pellets (minitabs), tablets and syrups in HIV-infected children.

http://www.wikidata.org/entity/Q38854786

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Acceptability of lopinavir/r p ...... rups in HIV-infected children.

@en

type

label

Acceptability of lopinavir/r p ...... rups in HIV-infected children.

@en

prefLabel

Acceptability of lopinavir/r p ...... rups in HIV-infected children.

@en

P1433

Q38854786-0ED6C0DF-0F84-4085-B335-DB43329B6A47

P1476

Q38854786-CDC24064-CB80-4B01-83D0-0F2A246B4580

P2093

Q38854786-36E4C20B-5924-4948-8AC6-F5318415DA8B

Q38854786-4CD3D22D-4FB7-473E-9892-E82B1016B09B

Q38854786-572A452D-1781-4F42-8FFC-E327EB56AC0E

Q38854786-646F0213-047C-4FEA-BCFB-16309D73D0CC

Q38854786-70344998-CDF6-45A1-B88A-12B3DB7B1991

Q38854786-71DC3E5C-77AE-400C-9E46-D3F4CFFCA27D

Q38854786-7210A453-87FF-4BF3-88A2-FF76241E1097

Q38854786-8C30FCBD-3048-4571-BDED-432CB9C972C7

P2860

Q38854786-296CBC55-FEFA-4357-B865-E220658AF0A6

Q38854786-596CCFAD-C099-4B81-9BF4-597A3D4E49E6

Q38854786-5CF5EC1C-A20F-49F4-A651-99A14570CF51

Q38854786-7B2F1F90-CE68-4A52-8EEC-1064586F6938

Q38854786-AFC5DADF-46FB-46D2-BDF4-B352DEB5F43B

Q38854786-DAC7B797-ABA0-4DFE-A780-974FA11667FA

Q38854786-E8D8E460-205C-427E-9826-97A381B01091

P304

Q38854786-5ECD9F25-58E0-4A7A-BA18-5F92BAD86F37

P31

Q38854786-DC780FF2-5C80-472E-9BA1-D25B499EA8C9

P356

Q38854786-37EAC581-A4CA-40EE-850A-4375CBD73538

P433

Q38854786-68892E59-4816-4C53-9F0D-CC184AEA5AFD

P478

Q38854786-18A28A59-E94A-4EF2-B2D2-8514B1703EC5

P50

Q38854786-315BD5DA-18A4-43F4-894A-FD4928D1958F

Q38854786-C54FC966-2492-42A7-B20A-E731B008FFC5

P577

Q38854786-EB310CED-09B1-4DC7-8F48-4D7182F97E5A

P698

Q38854786-ECD2988D-5E47-4085-9BD0-2B98842E4B73

P932

Q38854786-238CD227-DC4B-40FA-8367-31264CAE7B89

P356

P1433

Antiviral Therapy

P1476

Acceptability of lopinavir/r p ...... rups in HIV-infected children.

@en

P2093

A Sarah Walker

http://www.w3.org/2001/XMLSchema#string

Adeodata Kekitiinwa

http://www.w3.org/2001/XMLSchema#string

Ali Judd

http://www.w3.org/2001/XMLSchema#string

David Baptiste

http://www.w3.org/2001/XMLSchema#string

Diana M Gibb

http://www.w3.org/2001/XMLSchema#string

Grace Mirembe

http://www.w3.org/2001/XMLSchema#string

Margaret J Thomason

http://www.w3.org/2001/XMLSchema#string

Sarah Nakalanzi

http://www.w3.org/2001/XMLSchema#string

P2860

Consolidated Guidelines on the Use of Antiretroviral Drugs for Treating and Preventing HIV Infection: Recommendations for a Public Health Approach

Young HIV-infected children and their adult caregivers prefer tablets to syrup antiretroviral medications in Africa

Pharmacokinetics of lopinavir/ritonavir crushed versus whole tablets in children.

Factors related to antiretroviral therapy adherence in children and adolescents with HIV/AIDS in Cuba.

The pharmacokinetics and acceptability of lopinavir/ritonavir minitab sprinkles, tablets, and syrups in african HIV-infected children.

Adherence to tablet and liquid formulations of antiretroviral medication for paediatric HIV treatment at an urban clinic in Uganda.

Correlates of adherence to antiretroviral therapy in HIV-infected children in Lomé, Togo, West Africa.

P304

579-585

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3851/IMP3054

http://www.w3.org/2001/XMLSchema#string

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

21

http://www.w3.org/2001/XMLSchema#string

P50

P577

2016-04-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27128199

http://www.w3.org/2001/XMLSchema#string

P932

6029664

http://www.w3.org/2001/XMLSchema#string